Cargando…

Prevention of Cytotoxic T Cell Escape Using a Heteroclitic Subdominant Viral T Cell Determinant

High affinity antigen-specific T cells play a critical role during protective immune responses. Epitope enhancement can elicit more potent T cell responses and can subsequently lead to a stronger memory pool; however, the molecular basis of such enhancement is unclear. We used the consensus peptide-...

Descripción completa

Detalles Bibliográficos
Autores principales: Butler, Noah S., Theodossis, Alex, Webb, Andrew I., Nastovska, Roza, Ramarathinam, Sri Harsha, Dunstone, Michelle A., Rossjohn, Jamie, Purcell, Anthony W., Perlman, Stanley
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2563037/
https://www.ncbi.nlm.nih.gov/pubmed/18949029
http://dx.doi.org/10.1371/journal.ppat.1000186
_version_ 1782159790443593728
author Butler, Noah S.
Theodossis, Alex
Webb, Andrew I.
Nastovska, Roza
Ramarathinam, Sri Harsha
Dunstone, Michelle A.
Rossjohn, Jamie
Purcell, Anthony W.
Perlman, Stanley
author_facet Butler, Noah S.
Theodossis, Alex
Webb, Andrew I.
Nastovska, Roza
Ramarathinam, Sri Harsha
Dunstone, Michelle A.
Rossjohn, Jamie
Purcell, Anthony W.
Perlman, Stanley
author_sort Butler, Noah S.
collection PubMed
description High affinity antigen-specific T cells play a critical role during protective immune responses. Epitope enhancement can elicit more potent T cell responses and can subsequently lead to a stronger memory pool; however, the molecular basis of such enhancement is unclear. We used the consensus peptide-binding motif for the Major Histocompatibility Complex molecule H-2K(b) to design a heteroclitic version of the mouse hepatitis virus-specific subdominant S598 determinant. We demonstrate that a single amino acid substitution at a secondary anchor residue (Q to Y at position 3) increased the stability of the engineered determinant in complex with H-2K(b). The structural basis for this enhanced stability was associated with local alterations in the pMHC conformation as a result of the Q to Y substitution. Recombinant viruses encoding this engineered determinant primed CTL responses that also reacted to the wildtype epitope with significantly higher functional avidity, and protected against selection of virus mutated at a second CTL determinant and consequent disease progression in persistently infected mice. Collectively, our findings provide a basis for the enhanced immunogenicity of an engineered determinant that will serve as a template for guiding the development of heteroclitic T cell determinants with applications in prevention of CTL escape in chronic viral infections as well as in tumor immunity.
format Text
id pubmed-2563037
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-25630372008-10-24 Prevention of Cytotoxic T Cell Escape Using a Heteroclitic Subdominant Viral T Cell Determinant Butler, Noah S. Theodossis, Alex Webb, Andrew I. Nastovska, Roza Ramarathinam, Sri Harsha Dunstone, Michelle A. Rossjohn, Jamie Purcell, Anthony W. Perlman, Stanley PLoS Pathog Research Article High affinity antigen-specific T cells play a critical role during protective immune responses. Epitope enhancement can elicit more potent T cell responses and can subsequently lead to a stronger memory pool; however, the molecular basis of such enhancement is unclear. We used the consensus peptide-binding motif for the Major Histocompatibility Complex molecule H-2K(b) to design a heteroclitic version of the mouse hepatitis virus-specific subdominant S598 determinant. We demonstrate that a single amino acid substitution at a secondary anchor residue (Q to Y at position 3) increased the stability of the engineered determinant in complex with H-2K(b). The structural basis for this enhanced stability was associated with local alterations in the pMHC conformation as a result of the Q to Y substitution. Recombinant viruses encoding this engineered determinant primed CTL responses that also reacted to the wildtype epitope with significantly higher functional avidity, and protected against selection of virus mutated at a second CTL determinant and consequent disease progression in persistently infected mice. Collectively, our findings provide a basis for the enhanced immunogenicity of an engineered determinant that will serve as a template for guiding the development of heteroclitic T cell determinants with applications in prevention of CTL escape in chronic viral infections as well as in tumor immunity. Public Library of Science 2008-10-24 /pmc/articles/PMC2563037/ /pubmed/18949029 http://dx.doi.org/10.1371/journal.ppat.1000186 Text en Butler et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Butler, Noah S.
Theodossis, Alex
Webb, Andrew I.
Nastovska, Roza
Ramarathinam, Sri Harsha
Dunstone, Michelle A.
Rossjohn, Jamie
Purcell, Anthony W.
Perlman, Stanley
Prevention of Cytotoxic T Cell Escape Using a Heteroclitic Subdominant Viral T Cell Determinant
title Prevention of Cytotoxic T Cell Escape Using a Heteroclitic Subdominant Viral T Cell Determinant
title_full Prevention of Cytotoxic T Cell Escape Using a Heteroclitic Subdominant Viral T Cell Determinant
title_fullStr Prevention of Cytotoxic T Cell Escape Using a Heteroclitic Subdominant Viral T Cell Determinant
title_full_unstemmed Prevention of Cytotoxic T Cell Escape Using a Heteroclitic Subdominant Viral T Cell Determinant
title_short Prevention of Cytotoxic T Cell Escape Using a Heteroclitic Subdominant Viral T Cell Determinant
title_sort prevention of cytotoxic t cell escape using a heteroclitic subdominant viral t cell determinant
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2563037/
https://www.ncbi.nlm.nih.gov/pubmed/18949029
http://dx.doi.org/10.1371/journal.ppat.1000186
work_keys_str_mv AT butlernoahs preventionofcytotoxictcellescapeusingaheterocliticsubdominantviraltcelldeterminant
AT theodossisalex preventionofcytotoxictcellescapeusingaheterocliticsubdominantviraltcelldeterminant
AT webbandrewi preventionofcytotoxictcellescapeusingaheterocliticsubdominantviraltcelldeterminant
AT nastovskaroza preventionofcytotoxictcellescapeusingaheterocliticsubdominantviraltcelldeterminant
AT ramarathinamsriharsha preventionofcytotoxictcellescapeusingaheterocliticsubdominantviraltcelldeterminant
AT dunstonemichellea preventionofcytotoxictcellescapeusingaheterocliticsubdominantviraltcelldeterminant
AT rossjohnjamie preventionofcytotoxictcellescapeusingaheterocliticsubdominantviraltcelldeterminant
AT purcellanthonyw preventionofcytotoxictcellescapeusingaheterocliticsubdominantviraltcelldeterminant
AT perlmanstanley preventionofcytotoxictcellescapeusingaheterocliticsubdominantviraltcelldeterminant